A recent blood-based hepatitis C virus assay on Nuclein's DASH system highlighted its on-device sample prep, among other features that have been driving its adoption.

Certain serious fungal infections occur in regions of the United States with specific environments and are often tied to soil exposure. These infections can affect both healthy and immunocompromised ...

BD’s new MiniDraw diagnostic devices could let pharmacists—and, one day, maybe patients—manage blood testing needs and monitor health conditions. BD received its FDA authorizations for two blood draw ...

When cancer is detected earlier, it can improve outcomes for patients. Liquid biopsies are one way to improve cancer detection; these tests can analyze DNA in blood samples, which can reveal the ...

Conversations around controlling the $4.4 trillion in health care costs veer towards the 5% of the population who are most ill and "who account for 50% of all health care spending," many of whom have ...

The cobas Malaria test will be available at the end of the second quarter of 2024. The cobas Malaria test is also intended for use in testing whole blood samples to screen organ and tissue donors when ...

Please provide your email address to receive an email when new articles are posted on . Transplant advocates said a language change in Medicare payment policy would limit availability of a test used ...

A new blood test could diagnose pancreatic cancer much earlier, improving survival rates for people with the disease. A large part of the reason for this poor prognosis is that pancreatic cancer is ...

SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...

Immucor, Inc. announced that the U.S.Food and Drug Administration (FDA) has granted approval for the company's PreciseType HEA test. The PreciseType HEA test is the first FDA-approved molecular assay ...